Presented by the Interdisciplinary Neuroscience Program and the Ryan Institute:

  Principal Investigator Lab Manager Postdoctoral Fellow Graduate Students Undergraduate Students Past Trainees

    October 2024 Emily Reedich presented results from her work with the Manuel lab at the Society for Neuroscience annual meeting in Chicago: “This year, the SfN Annual Meeting drew more than 20,000 attendees,” said Reedich, who also presented a poster with the Ryan Institute’s Quinlan lab. “The breadth of neuroscience research presented at […]

  Publications *Ryan Institute affiliation Nascimento, Filipe, M. Görkem Özyurt, Kareen Halablab, Gardave Singh Bhumbra, Guillaume Caron, Marcin Bączyk, Daniel Zytnicki, et al. Spinal Microcircuits Go through Multiphasic Homeostatic Compensations in a Mouse Model of Motoneuron Degeneration. Cell Reports 43, no. 12, 2024.  Reedich EJ,* Genry LT,* Steele PR,* Mena Avila E,* Dowaliby L,* Drobyshevsky A, […]

  The Manuel Lab focuses on unraveling the intricacies of the motor system and understanding how normal motor function is impacted in pathological conditions. Employing a range of cutting-edge techniques, including in vivo electrophysiology, in vitro electrophysiology, viral approaches, and advanced imaging methods, our research aims to shed light on the underlying mechanisms governing motor […]

Her inspiration, the biggest challenges in her work, and what makes her feel hopeful. Assistant Professor Jessica Alber investigates the potential to use retinal imaging as a screening tool for early-stage Alzheimer’s disease. Performed during a routine eye exam, the screening technique could help provide a low-cost, minimally invasive way to detect Alzheimer’s disease before […]

Ryan Institute Co-Executive Director William Van Nostrand answers questions about the potential risk of brain bleeds associated with newly-approved lecanemab and similar treatments. This summer, the FDA granted full approval to lecanemab, an antibody treatment for Alzheimer’s disease.  The antibody—a protein that works by clearing amyloid-beta protein “plaques” in the brain, a signature of Alzheimer’s disease—has […]